| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,085 | 14,317 | 6,594 | 11,635 | | Cost of Revenue | 6,252 | 6,219 | 4,826 | 6,193 | | | Gross Profit | 5,833 | 8,098 | 1,768 | 5,442 | | | Operating Expenses | | Research Development | 999 | 1,119 | 1,083 | 1,535 | | Selling General and Administrative | 3,930 | 4,505 | 5,614 | 6,902 | | Non Recurring |
-
|
-
|
-
| 1,819 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 904 | 2,474 | (4,929) | (4,814) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (39) | (107) | 316 | (382) | | Earnings Before Interest And Taxes | 865 | 2,367 | (4,613) | (5,196) | | Interest Expense | 7 | 12 | 30 | 62 | | Income Before Tax | 858 | 2,355 | (4,643) | (5,258) | | Income Tax Expense | (1) | 25 | 33 | 29 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 859 | 2,330 | (4,676) | (5,287) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 859 | 2,330 | (4,676) | (5,287) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $859 | $2,330 | ($4,676) | ($5,287) |
|
0.83% Nasdaq 0.00%
Income Statement
